Who are Hydroxytyrosol plus Vitamin E's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): vitamin E +Selenium, Vitamins E + C, Rutin + Vitamin C, Rosiglitazone/alpha-lipoic acid, Combined antioxidant therapy, Cytoflavin® solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hydroxytyrosol-plus-vitamin-e.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hydroxytyrosol plus Vitamin E — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hydroxytyrosol plus Vitamin E (Hydroxytyrosol plus Vitamin E) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antioxidant combination. Area: Neurology.

phase 3 Antioxidant combination Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Hydroxytyrosol plus Vitamin E (Hydroxytyrosol plus Vitamin E) — Bambino Gesù Hospital and Research Institute. Hydroxytyrosol and Vitamin E work synergistically as antioxidants to reduce oxidative stress and inflammation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Hydroxytyrosol plus Vitamin E TARGET	Hydroxytyrosol plus Vitamin E	Bambino Gesù Hospital and Research Institute	phase 3	Antioxidant combination
vitamin E +Selenium	vitamin E +Selenium	Tehran University of Medical Sciences	marketed	Nutritional supplement / Antioxidant combination
Vitamins E + C	Vitamins E + C	University Hospital, Aker	marketed	Vitamin supplement / Antioxidant combination
Rutin + Vitamin C	Rutin + Vitamin C	Ain Shams University	marketed	Antioxidant combination / Nutraceutical
Rosiglitazone/alpha-lipoic acid	Rosiglitazone/alpha-lipoic acid	Seoul St. Mary's Hospital	marketed	Thiazolidinedione + antioxidant combination	PPAR-γ (rosiglitazone); mitochondrial oxidative stress (alpha-lipoic acid)
Combined antioxidant therapy	Combined antioxidant therapy	University of Guadalajara	phase 3	Antioxidant combination therapy
Cytoflavin® solution	Cytoflavin® solution	POLYSAN Scientific & Technological Pharmaceutical Company	phase 3	Metabolic activator / Antioxidant combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antioxidant combination class)

Bambino Gesù Hospital and Research Institute · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hydroxytyrosol plus Vitamin E — Competitive Intelligence Brief. https://druglandscape.com/ci/hydroxytyrosol-plus-vitamin-e. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing